StockData
Lakewood-Amedex Biotherapeutics Inc. logo

Lakewood-Amedex Biotherapeutics Inc. (LABT) stock

LABTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026
$0.21−0.00 (-2.23%)

Close on Nov 17, 2026Market cap $508.30KP/E –Yield –

Lakewood-Amedex Biotherapeutics total assets

Total assets on the balance sheet at the end of each period.

Lakewood-Amedex Biotherapeutics's total assets was $3.60M at Sep 30, 2026. For fiscal 2025 it was $481.60K.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$481.60K–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$3.60M–
Q2 FY2026Jun 30, 2026$4.96M–
Q1 FY2026Mar 31, 2026$196.34K–
Q4 FY2025Dec 31, 2025$481.60K–

More Lakewood-Amedex Biotherapeutics figures

See a number that looks wrong?